KR20240134913A - 수성 액제 - Google Patents

수성 액제 Download PDF

Info

Publication number
KR20240134913A
KR20240134913A KR1020247024814A KR20247024814A KR20240134913A KR 20240134913 A KR20240134913 A KR 20240134913A KR 1020247024814 A KR1020247024814 A KR 1020247024814A KR 20247024814 A KR20247024814 A KR 20247024814A KR 20240134913 A KR20240134913 A KR 20240134913A
Authority
KR
South Korea
Prior art keywords
aqueous solution
albekacin
water
salt
soluble polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247024814A
Other languages
English (en)
Korean (ko)
Inventor
유메나 니시다
유키 나카무라
다츠야 사카이
Original Assignee
센주 유에스에이, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 센주 유에스에이, 인코포레이티드 filed Critical 센주 유에스에이, 인코포레이티드
Publication of KR20240134913A publication Critical patent/KR20240134913A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
KR1020247024814A 2022-01-21 2023-01-20 수성 액제 Pending KR20240134913A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2022-007774 2022-01-21
JP2022007774 2022-01-21
PCT/JP2023/001725 WO2023140357A1 (ja) 2022-01-21 2023-01-20 水性液剤

Publications (1)

Publication Number Publication Date
KR20240134913A true KR20240134913A (ko) 2024-09-10

Family

ID=87348335

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247024814A Pending KR20240134913A (ko) 2022-01-21 2023-01-20 수성 액제

Country Status (8)

Country Link
US (2) US12296015B2 (https=)
EP (1) EP4467144A4 (https=)
JP (2) JP7479744B2 (https=)
KR (1) KR20240134913A (https=)
CN (1) CN118613267A (https=)
CA (1) CA3244189A1 (https=)
MX (1) MX2024009025A (https=)
WO (1) WO2023140357A1 (https=)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070270378A1 (en) 2004-05-27 2007-11-22 Santen Pharmaceutical Co., Ltd. Viscous Agent for Ophthalmic Use
US9511143B2 (en) 2011-09-12 2016-12-06 Meiji Seika Pharma Co., Ltd. Aqueous compositions comprising arbekacin
US20200016176A1 (en) 2015-07-27 2020-01-16 Catacore, Inc. Compositions for the treatment of cataracts

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5651499A (en) 1979-10-01 1981-05-09 Meiji Seika Kaisha Ltd Aminoglycoside derivative and its preparation
JPS58134099A (ja) 1982-02-05 1983-08-10 Meiji Seika Kaisha Ltd アミノ配糖体抗生物質の精製法
JP2002097129A (ja) * 2000-07-21 2002-04-02 Rohto Pharmaceut Co Ltd 点眼剤
EP1683526B1 (en) * 2003-11-14 2012-04-11 Senju Pharmaceutical Co., Ltd. Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac
JP4736540B2 (ja) * 2004-05-27 2011-07-27 参天製薬株式会社 眼科用粘稠化剤
US8748402B2 (en) * 2004-06-07 2014-06-10 Bausch & Lomb Pharma Holdings Corp. Ophthalmic formulations and uses thereof
CN105944105A (zh) 2008-06-12 2016-09-21 前瞻生物治疗公司 一种眼科组合物中的防腐剂替代物聚维酮碘
WO2010141831A1 (en) * 2009-06-05 2010-12-09 Aciex Therapeutics, Inc. Ophthalmic formulations, methods of manufacture, and methods of using same
US8211450B2 (en) * 2010-05-05 2012-07-03 Senju Usa, Inc. Ophthalmic composition
CN106474149A (zh) * 2016-12-23 2017-03-08 常州润诺生物科技有限公司 一种复方氨基糖苷类抗生素的口服制剂及其制备方法与应用
CN106420811A (zh) * 2016-12-23 2017-02-22 常州润诺生物科技有限公司 一种氨基糖苷类抗生素的口服制剂及其制备方法与应用

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070270378A1 (en) 2004-05-27 2007-11-22 Santen Pharmaceutical Co., Ltd. Viscous Agent for Ophthalmic Use
US9511143B2 (en) 2011-09-12 2016-12-06 Meiji Seika Pharma Co., Ltd. Aqueous compositions comprising arbekacin
US20200016176A1 (en) 2015-07-27 2020-01-16 Catacore, Inc. Compositions for the treatment of cataracts

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
AdvClin Exp Med. 2019; 28(2): 165-169.
ClinPharmacol. 2014 Sep 26; 6: 139-48.
Int.J. Pharm. Sci. Rev. Res. 2014, 24(1), 237-245.
InternationalJournal of Pharmaceutics, 1989; 53(3): 219-225
JColloid Interface Sci. 2003 Jun 1; 262(1): 130-48.
PharmRes. 1990 May; 7(5): 491-5.
TFOSDEWS II Report Executive Summary, The Ocular Surface(2017), http://dx.doi.org/10.1016/j.jtos.2017.08.003
VetOphthalmol. Mar-Apr 2004; 7(2): 71-7.
새로운 안과 Vol.22, No.3, 2005, 289-294.

Also Published As

Publication number Publication date
CA3244189A1 (en) 2025-06-13
US12296015B2 (en) 2025-05-13
JPWO2023140357A1 (https=) 2023-07-27
JP2024096898A (ja) 2024-07-17
MX2024009025A (es) 2024-08-06
EP4467144A1 (en) 2024-11-27
WO2023140357A1 (ja) 2023-07-27
US20250235541A1 (en) 2025-07-24
EP4467144A4 (en) 2026-01-21
JP7479744B2 (ja) 2024-05-09
CN118613267A (zh) 2024-09-06
US20240307544A1 (en) 2024-09-19

Similar Documents

Publication Publication Date Title
Steven et al. Preservatives in glaucoma medication
KR101809713B1 (ko) 방부제 없는 프로스타글란딘계 비점성 용액의 고분자 전달 시스템
KR101702157B1 (ko) 안과용 조성물
EA034839B1 (ru) Офтальмологический раствор
CN107708416B (zh) 肽组合物和使用方法
JP2018203791A (ja) 眼科用アレルギー予防剤
CA3002384A1 (en) Pharmaceutical formulations that form gel in situ
CN104661682B (zh) 水性液剂
Al-Bazzaz et al. Ophthalmic in-situ sustained gel of ciprofloxacin, preparation and evaluation study
CN118975979A (zh) 稳定的肽组合物
JP7796305B2 (ja) ジフルプレドナートを含むインサイチュゲル形成性眼科用製剤
JP2026035663A (ja) 高分子量ヒアルロン酸の眼科用薬物輸送ビヒクルとしての使用
US20200171124A1 (en) Topical compositions for ophthalmic and otic use
KR102281853B1 (ko) 열겔화 인공 누액
JP2022164840A (ja) 眼科組成物
KR20240134913A (ko) 수성 액제
JP5834427B2 (ja) ソフトコンタクトレンズへの吸着抑制方法
US20220017602A1 (en) Ocular compositions and methods
CN105530936A (zh) 两性离子性软隐形眼镜用眼科用组合物
JP6503085B2 (ja) ドライアイ疾患を治療及び／又は予防するための短い合成ペプチドの使用
RU2842860C1 (ru) Водная суспензионная композиция, содержащая сиролимус или его соль
WO2025018419A1 (ja) 水性液剤
HK40111552A (zh) 用於治疗干眼综合征的包含瑞可黄酮的滴眼剂组合物及其制备方法
TW201534351A (zh) 兩性離子性軟式隱形眼鏡用眼科用組成物
JP2024528234A (ja) レコフラボン（ｒｅｃｏｆｌａｖｏｎｅ）を含有するドライアイ症候群を処置するための点眼組成物及びそれを製造するための方法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000